Merit Medical Systems To Announce Second Quarter 2025 Results On July 30, 2025
Merit Medical Systems (NASDAQ: MMSI), a leading healthcare technology manufacturer, has scheduled its second quarter 2025 financial results announcement for July 30, 2025, after market close. The company will host an investor conference call the same day at 5:00 p.m. Eastern Time.
Founded in 1987, Merit Medical specializes in proprietary medical devices for interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. The company maintains a global presence with over 800 sales and clinical support professionals and approximately 7,300 employees worldwide.
Merit Medical Systems (NASDAQ: MMSI), un produttore leader nel settore della tecnologia sanitaria, ha programmato l'annuncio dei risultati finanziari del secondo trimestre 2025 per il 30 luglio 2025, dopo la chiusura del mercato. La società terrà una conference call per gli investitori lo stesso giorno alle 17:00 ora della costa orientale.
Fondata nel 1987, Merit Medical è specializzata in dispositivi medici proprietari per procedure interventistiche, diagnostiche e terapeutiche, in particolare in cardiologia, radiologia, oncologia, terapia intensiva ed endoscopia. L'azienda ha una presenza globale con oltre 800 professionisti nelle vendite e nel supporto clinico e circa 7.300 dipendenti in tutto il mondo.
Merit Medical Systems (NASDAQ: MMSI), un fabricante líder en tecnología sanitaria, ha programado el anuncio de sus resultados financieros del segundo trimestre de 2025 para el 30 de julio de 2025, después del cierre del mercado. La compañía realizará una conferencia telefónica para inversores ese mismo día a las 5:00 p.m. hora del Este.
Fundada en 1987, Merit Medical se especializa en dispositivos médicos patentados para procedimientos intervencionistas, diagnósticos y terapéuticos, especialmente en cardiología, radiología, oncología, cuidados críticos y endoscopía. La empresa cuenta con presencia global con más de 800 profesionales de ventas y soporte clínico y aproximadamente 7,300 empleados en todo el mundo.
Merit Medical Systems (NASDAQ: MMSI)는 선도적인 의료 기술 제조업체로서 2025년 2분기 재무 실적 발표를 2025년 7월 30일 시장 마감 후에 예정하고 있습니다. 회사는 같은 날 동부 표준시 오후 5시에 투자자 컨퍼런스 콜을 개최할 예정입니다.
1987년에 설립된 Merit Medical은 심장학, 방사선학, 종양학, 중환자 치료 및 내시경 분야에서 특히 개입적, 진단적, 치료적 절차를 위한 독자적인 의료기기 전문 회사입니다. 전 세계에 걸쳐 800명 이상의 영업 및 임상 지원 전문가와 약 7,300명의 직원을 보유하고 있습니다.
Merit Medical Systems (NASDAQ : MMSI), un fabricant leader de technologies de santé, a prévu d’annoncer ses résultats financiers du deuxième trimestre 2025 le 30 juillet 2025, après la clôture du marché. La société tiendra une conférence téléphonique pour les investisseurs le même jour à 17h00, heure de l’Est.
Fondée en 1987, Merit Medical est spécialisée dans les dispositifs médicaux propriétaires pour les procédures interventionnelles, diagnostiques et thérapeutiques, notamment en cardiologie, radiologie, oncologie, soins intensifs et endoscopie. L’entreprise est présente à l’échelle mondiale avec plus de 800 professionnels des ventes et du support clinique et environ 7 300 employés dans le monde.
Merit Medical Systems (NASDAQ: MMSI), ein führender Hersteller von Medizintechnik, hat die Bekanntgabe der Finanzergebnisse für das zweite Quartal 2025 für den 30. Juli 2025 nach Börsenschluss geplant. Das Unternehmen wird am selben Tag um 17:00 Uhr Eastern Time eine Telefonkonferenz für Investoren abhalten.
Gegründet im Jahr 1987, spezialisiert sich Merit Medical auf proprietäre medizinische Geräte für interventionelle, diagnostische und therapeutische Verfahren, insbesondere in den Bereichen Kardiologie, Radiologie, Onkologie, Intensivmedizin und Endoskopie. Das Unternehmen ist weltweit mit über 800 Vertriebs- und klinischen Supportmitarbeitern und etwa 7.300 Mitarbeitern weltweit vertreten.
- None.
- None.
SOUTH JORDAN, Utah, July 03, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the quarter ended June 30, 2025, after the close of the stock market on Wednesday, July 30, 2025. Merit plans to hold its investor conference call on the same day (Wednesday, July 30, 2025) at 5:00 p.m. Eastern (4:00 p.m. Central, 3:00 p.m. Mountain, and 2:00 p.m. Pacific).
To access the conference call, please pre-register using the following link. Registrants will receive confirmation with dial-in details.
A live webcast and slide deck can be accessed using this link. A link to both register for the conference call and view the webcast will be made available at www.merit.com.
ABOUT MERIT
Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of proprietary medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Merit serves customers worldwide with a domestic and international sales force and clinical support team totaling more than 800 individuals. Merit employs approximately 7,300 people worldwide.
| Contacts: | |
| PR/Media Inquiries: | Investor Inquiries: |
| Sarah Comstock | Mike Piccinino, CFA, IRC |
| Merit Medical | ICR Healthcare |
| +1-801-432-2864 | +1-443-213-0509 |
| sarah.comstock@merit.com | mike.piccinino@icrhealthcare.com |
FAQ
When will Merit Medical (MMSI) report Q2 2025 earnings?
How can investors access Merit Medical's Q2 2025 earnings call?
What are Merit Medical's main business segments?
How many employees does Merit Medical (MMSI) have?
